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Introduction
DNA damage is a trigger of many pathological processes;
therefore, knowledge of the molecular mechanisms and
targets of antimutagens is important for understanding
their etiology and pathogenesis. Antimutagenic effects
may also be important from the point of view of normal
tissue protection during cancer radiotherapy. We have
earlier shown that the 1,4-dihydropyridine derivatives
are efficient antimutagens and DNA repair modulators
in vivo [3, 8, 9, 11, 12] and in vitro [15, 16]. In particular,
alkaline single cell gel electrophoresis (comet) assays
showed that DHP (sodium 3,5-bis-ethoxycarbonyl-2,6-
dimethyl-1,4-dihydropyridine-4-carboxylate, previously
designated as AV-153 [16]) reduced the number of
endogenously generated DNA strand breaks in untreated
human lymphocytes and human promyelocytic
leukemia HL-60 cells [16]. In HL-60 and Raji (human
B-lymphoblastic leukemia) cells exposed to 2 Gy of
γ-radiation or 100 µM hydrogen peroxide there was
a statistically significant increase in the single strand
break rejoining rate [16]. Another compound of
1,4-DHP series, glutapyrone (disodium salt of 2-(2,6-
dimethyl-3,5-diethoxycarbonyl-1,4-dihydropyridine-4-
carboxamido)-glutaric acid), protected against ethyl
methanesulfonate (EMS)-induced mutations in
Drosophila melanogaster and chromosome breakage
in mouse bone marrow [9, 11, 12].
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Abstract  In a series of studies it was shown that 1,4-dihydropyridine derivatives (1,4-DHP) show antimutagenic and
anticlastogenic properties and accelerate repair of oxidant and ionising radiation generated DNA damage. Here, effects
of one of 1,4-DHP compounds (sodium 3,5-bis-ethoxycarbonyl-2,6-dimethyl-1,4-dihydropyridine-4-carboxylate denoted
as DHP) in X-irradiated L5178Y cells (murine lymphoma sublines, LY-R and LY-S) are reported. DHP treatment 1 h
before, during and after X-irradiation gave a radioprotective effect in double strand break (DSB) repair competent LY-R
cells: there was an increase in post-irradiation proliferation and cell viability as well as a slight acceleration of break
rejoining as measured by the neutral comet assay. In the radiosensitive LY-S cells with impaired non-homologous end-
joining system, the radioprotective effect was seen as enhanced growth and viability. There was, however, no effect on
the DSB repair rate. Notably, there was no dependence of the biological effects on DHP concentration in the range of
concentrations studied (1 nM − 100 µM), suggesting an all-or-none effect, as in cellular signaling induction observed in
radioadaptation or bystander effect. We assume that DHP acts by decreasing fixation of radiation inflicted DNA damage,
among others, by increasing the rate of DNA repair and enhancing the efficiency of checkpoint control. Direct
confirmation of this assumption is necessary.










142 O. Dalivelya et al.
The purpose of the reported investigation has been
to study the influence of an antimutagen of 1,4-dihydro-
pyridine series on cell survival and X-ray-induced DNA
damage in L5178Y murine sublines differing in radio-
resistance, repair of double strand breaks and metabolism
of poly(ADP-ribose) (reviewed in [17, 18]). The present
study is part of screening of 1,4-DHP derivatives
synthesized in the Latvian Institute of Organic Synthesis.
Materials and methods
Cell culture
Two sublines of murine lymphoma L5178Y, LY-R and
LY-S, were used, earlier characterized in detail [17, 19].
Cells of both sublines were maintained in logarithmic
growth phase in RPMI-1640 medium supplemented
with 10% heat inactivated fetal calf serum at 37°C and
5% CO2.
 For estimation of cell growth and viability,
suspensions of cell density 25 × 103/ml (for treatment
procedures without X-irradiation) and 100 × 103/ml (for
irradiated cells) were used. The comet assay (single cell
gel-electrophoresis) was carried out at cell density no
less than 400 × 103/ml.
Treatment procedures
Exponentially growing cells were irradiated on 60 mm
plastic Petri dishes with an X-ray machine at room tem-
perature, with the use of an X-ray machine (ANDREX,
Holger Andreasen, Denmark, 200 kVp, 5 mA, dose rate
1.2 Gy/min). Since the cell lines differ in radiosensitivity,
approximately equitoxic doses of X-rays were used for
irradiation: 1 Gy for LY-S and 2 Gy for LY-R cells. In
cell growth and viability tests, X-irradiated cells were
incubated at 37°C for 48 h. In the comet assay, cells of
both sublines were irradiated with 10 Gy of X-rays at
0°C for estimation of initial DNA damage and at 37°C
for repair analysis 15, 60 and 120 min after irradiation.
The 1,4-dihyropyridine derivative (DHP) at concen-
trations of 1 nM, 1 µM and 100 µM was added to the
culture medium 1 h before irradiation and present there
for the whole 48 h incubation in the growth and viability
tests and from 0 to 120 min after irradiation in the comet
assay. In micronuclei frequency determination, 1 h pre-
treatment before irradiation at concentrations of 1 nM
or 100 µM DHP was carried out and DHP left to the
end of post-irradiation incubation. (1 mM DHP was used
to treat non-irradiated cells for comparison to control.)
Growth and viability tests
In growth tests, cell cultures, control and treated with
DHP at concentrations indicated, were grown from the
same cell density for 48 h. Relative cell numbers were
determined (ratio of cell number in the treated culture
to that in the control; direct count of morphologically
normal cells), as well as viability by the dye exclusion
test with trypan blue, as described below. Experiments
were repeated at least 2 times.
Viability of cells subjected to X-irradiation and/or
DHP treatment was estimated with the standard trypan
blue test. For this purpose, irradiated or non-irradiated
cells of both sublines were incubated for 48 h in the
presence or absence of DHP, whereupon the dye was
added at a final concentration of 0.2 mg/ml. The cells
were scored using a Buerker hemocytometer.
Neutral comet assay
The modified method of neutral comet assay (single
cell gel electrophoresis) [23] was used for estimation
of DNA damage (predominantly DSB) and kinetics of
their rejoining. The cell suspensions (4 × 105 cells/ml)
were mixed with an equal volume of low melting-point
agarose Type VII at a final concentration of 0.75%. Cell
suspensions were cast on microscope slides precoated
with 0.5% normal (regular) agarose Type IA. Samples
were covered with cover slips and left on ice for
solidification. Then, they were placed in a lysing buffer
(2.5 M NaCl, 100 mM EDTA, 10 mM Tris-HCl, 1%
N-lauroylsarcosine, pH 9.5) supplemented with 0.5%
Triton X-100 and 10% DMSO. Lysis was carried out
for 1−2 h at 4°C in the dark. After lysis, the slides were
washed three times with an electrophoresis buffer
(300 mM sodium acetate, 100 mM Tris-HCl, pH 8.3)
and left in a fresh portion of the buffer for 1 h, then
placed in a horizontal gel electrophoresis unit filled with
a fresh electrophoresis buffer. The samples were
electrophoresed for 1 h at 14 V (0.5 V/cm, 7−8 mA) at
8°C in the dark. After electrophoresis, the slides were
rinsed with 0.4 M Tris (pH 7.5) and then stained with
1 µM 4,6-diamidine-2-phenylindole dihydrochloride
(DAPI, 50 µl per slide). For image analysis, pictures of
50 randomly selected comets per slide from two slides
in three separate experiments were captured at 200×
magnification using an epifluorescence microscope
(Labophob-2, Nikon) equipped with a UV-1A filter
block. Image analysis was carried out using the Comet
v.3.1 (Kinetic Imaging Ltd., Liverpool, UK). The
measure of damage was the tail moment (fraction of
DNA in the tail times tail length). Data analysis was
based on the mean population response or on the
distributions of damage among cells. Statistical
evaluation and plots were prepared with Microsoft
Excel 2000 software.
Micronuclei frequency determination
Microscopic preparations for the cytokinesis block
micronucleus technique were made according to
Fenech and Morley [4]. Briefly, cell cultures were
incubated for 1 h with 1 nM or 100 µM DHP,
X-irradiated (1 Gy, LY-S; 2 Gy, LY-R cells) and
incubated for 16 h with 6 µM/ml cytochalasin B (Sigma)
added immediately after irradiation. For micronuclei
scoring, cells were subjected to a hypotonic treatment
with 144 mM KCl solution (5 min, room temperature)
and fixed in a cold methanol-glacial acetic acid solution
(3:1). Microscopic preparations were made by dropping
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cells were also treated in the same way with 1 µM DHP
to compare with the non-treated control. Also in that
case, DHP was left for the whole 16 h incubation time.
The procedure was according to Fenech [4]. Two
microscopic slides were prepared for each experimental
point and 1000 or 2000 cells scored. The experiment
was repeated 3 times.
Results
Effects of DHP on cell viability and proliferation
Cytotoxicity of DHP at the concentrations of 1 nM,
1 µM and 100 µM was estimated in the trypan blue test
after 48 h cell incubation in the presence or in the
absence of DHP. Effect on cell proliferation was
estimated in a 48 h growth test on the basis of relative
cell numbers, as defined in the “Materials and methods”
section.
The results are presented in Table 1 (numerical data
and statistical significance from Student’s t test) and in
Fig. 1. In non-irradiated cells, DHP reduced the relative
cell number by 30% in LY-R cells and by 50% in LY-S
cells. The effect was independent of DHP concentra-
tion. In both LY sublines there was a slight decrease in
percentage of dead cells. Thus, altered viability level
could not affect proliferation; therefore, the decrease
in relative cell number apparently resulted from slowed
down cell cycle progression.
In contrast, there was an increase in relative cell
numbers in cell populations after exposure to X-rays
(LY-R cells, 2 Gy; LY-S cells, 1 Gy) by 34−53% in LY-R
cells and by about 14% in LY-S cells. In both LY
sublines, this protective effect was reflected in viability
increase, albeit to a different extent. The level of dead
Table 1. Effects of DHP (1,4-dihydropyridine derivative) on cell growth and viability of LY sublines after X-irradiation with
2 Gy (LY-R) or 1 Gy (LY-S)
Treatment  Subline LY-R Subline LY-S
Relative  Dead cells        t; P* Relative   Dead cells        t; P*
cell number         [%] cell number          [%]
Control (non-irradiated)   1 2.13 ± 0.20 1   1.13 ± 0.13   4.17; <0.001
DHP 1 nM   0.72 2.43 ± 0.23 1.00; >0.05 0.51   0.39 ± 0.19   3.22; <0.001
DHP 1 µM   0.71 1.82 ± 0.23 1.03; >0.05 0.50   0.36 ± 0.19   3.35; <0.001
DHP 100 µM   0.65 1.66 ± 0.24 1.52; >0.05 0.48   0.61 ± 0.20   2.17; <0.05
X-irradiated   1 5.30 ± 0.19 1 10.75 ± 0.13 23.70; <0.0001
DHP 1 nM   1.34 4.31 ± 0.17 3.96; <0.001 1.21   5.42 ± 0.12 29.61; <0.0001
DHP 1 µM   1.45 4.10 ± 0.16 4.14; <0.001 1.09   6.69 ± 0.13 22.56; <0.0001
DHP 100 µM   1.53 4.72 ± 0.16 2.00; <0.05 1.13   6.58 ± 0.13 23.17; <0.0001
   * Student’s test evaluation of the difference from control (non-irradiated) or radiation alone data; t value and probability (P). Mean
results from 3 experiments.
Fig. 1. Influence of DHP on dead cell percentage in LY-R and LY-S cells relative to the control level taken as 100% (non-
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LY-R cells decreased by 10–20% only, that in LY-S
subline was reduced by up to 60%. As in the case of
unirradiated cells, there was no clear dose-dependent
relationship in the latter case: the lowest dose (1 nM)
was equally or even more effective than the higher doses
of DHP.
Effects of DHP on repair of X-ray-induced DNA
damage
Effect of DHP treatment in X-irradiated LY cells was
also studied with the use of the neutral comet assay. To
estimate the DHP influence on the endogenously
generated DNA damage, the dose of 1 µM was chosen,
whereas in experiments with irradiated cells, the effect
of treatment with 1 nM and 100 µM DHP was analysed.
The average tail moment value in LY-S cells (11.11 ±
0.37) exceeded that in LY-R cells (8.73 ± 0.1). DHP
treatment did not affect much these values (LY-S,
11.99 ± 0.38; LY-R, 9.96 ± 0.32). It must be taken into
consideration that tail moment value is a result not only
of the endogenously generated (“spontaneous”) DNA
breakage level, but also of chromatin conformation.
Kinetics of DNA damage induced by X-rays in LY-R
and LY-S cells treated or untreated with the 1,4-DHP
derivative is presented in Fig. 2. In cells of both sublines,
the main portion of induced DSBs was rejoined for the
first hour of cell incubation, with about 60% of DNA
damage being repaired during the first 15 min. In LY-R
cells (Fig. 2A), DHP decreased the level of X-ray-induced
DNA damage both immediately after irradiation and
during a later incubation. It was interesting to note that
the lowest and the highest doses of DHP were equally
efficient against X-rays in this subline. When the tail
moment value after X-irradiation alone was taken as
100%, then approximately 20% and more than 50% of
X-ray-induced DNA damage was reduced at 0 min and
60 min, respectively, indicating an increased rate of
DNA repair in the presence of DHP. It should be noted,
however, that although a tendency to accelerated repair
was reflected in these relative damage levels, the
differences between absolute tail moment values were
not statistically significant. Also, the residual damage
level was identical in DHP-treated and untreated cells.
In LY-S cells both 1 nM and 100 µM DHP did not
alter the rate of break rejoining both in absolute
(Fig. 2B) and relative (not shown) tail moment values.
The level of control and control + 1 µM DHP is
indicated in the figure and it can be seen that there
is no effect of DHP on tail moment in non-irradiated
cells of both sublines.
Effects of DHP on micronuclei frequency
To check whether the effect of DHP treatment on DNA
damage estimated with the comet assay is reflected in
chromosomal damage, we determined the frequency
of micronuclei in cells treated in a similar way as in
the other tests, except that the endpoint was generation
of micronuclei at 16 h after irradiation.
Although X-irradiation was carried out with
approximately equitoxic doses, the response of LY
sublines considerably differed because of different
duration of the G2 arrest: 4 h per Gy in LY-R cells and
11 h per Gy in LY-S cells as well as the apoptosis
proneness [19]. This is reflected in the % of binucleated
cells in the DHP-treated and X-irradiated cell
populations (Fig. 3). A difference could be seen between
LY sublines, in agreement with the radiation sensitivity,
but DHP + X treatment did not alter the percentage
of binucleated cells as compared with X alone. Thus,
the progression through the cell cycle leading to
successful mitosis did not seem to be affected by the
treatment.
For micronuclei frequency, only preliminary data are
available which, however, are consistent with the comet
assay results. Also here, the effect did not depend on
DHP concentration, so, the results for 1 nM and
100 µM were pooled. With micronuclei frequency after
X-irradiation alone taken as 100%, the relative fre-
quency (%) for DHP + X treated LY-R cells was 72.92
± 1.77 (mean ± standard deviation) and this decrease
was significant (chi square test, χ2 = 8.7); for LY-S cells
the decrease was not significant (68.23 ± 10.42).
Fig. 2. Time course of rejoining of X-ray-induced DNA breaks in LY-R (A) and LY-S (B) cells untreated or treated with
1 nM or 100 µM DHP (present 1 h before irradiation and during the whole repair interval). The results for both concentrations
were pooled because of lack of dependence on DHP concentration. The level of control and control + 1 µM DHP is indicated.
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Discussion
The present study is part of screening of DHP deriva-
tives synthesized in the Latvian Institute of Organic
Synthesis. So far, a pronounced antimutagenic and anti-
clastogenic activity was noted in studies on Drosophila
melanogaster, murine tissues, human lymphocytes and
a variety of human cancer cell lines [3, 8, 9, 11, 15, 16].
There were, however, few attempts at defining the
mechanism of action of this group of compounds, except
that accelerated DNA repair was seen, as estimated with
the alkaline comet assay after treatment with hydrogen
peroxide or methyl methane-sulfonate (MMS) as well
as after γ-irradiation [16].
In studies with Drosophila melanogaster, the anti-
mutagenic efficiency of 1,4-DHP derivatives was shown
to depend on their electron-donating activity [8]; hence,
they may act as antioxidants against spontaneous
mutations. However, the protective effect against EMS
supports the assumption that DHP derivatives also
modulate DNA repair [11, 12, 15, 16], and indeed,
accelerated rejoining of single strand breaks was
observed [16]. Moreover, DHP considerably stimulated
synthesis of poly(ADP-ribose) polymers and the
increase correlated with an increase in DNA repair rate
in hydrogen peroxide treated cells [15]. As discussed
below, other possible targets of 1,4-DHP derivatives
include progression through the cell cycle, DNA damage
repair and fixation processes (notably, both dependent
on poly(ADP-ribosylation)) and calcium ion homeostasis.
The observations on LY cells, reported above,
indicate that the effect on DSB repair may be important
in the radioprotective activity, since − as summarised in
Table 2 − this effect was weaker in LY-S cells that are
DSB repair-defective (reviewed in [20]). Nevertheless,
some protection was observed even in these cells,
indicated by determinations of relative cell number and
viability tests. It seems of importance that DHP consi-
derably slowed down proliferation of non-irradiated
cells. Moreover, this effect was independent of DHP
concentration (see Fig. 1). In another study, DHP treat-
ment did not alter the distribution in cell cycle phases
[16], thus, apparently not causing any arrest at a specific
checkpoint; neither did it exert any lethal effect, as
judged from the viability tests. Hence, it was plausible
to assume that DHP facilitated or enhanced this aspect
of the cellular response to DNA damage that consisted
in arrest in cell cycle progression. The arrest depends
on a complicated signaling system (review in [13]) and
exerts a protective effect by favoring repair and preventing
damage fixation. Nevertheless, the percent-age of
binucleated cells (Fig. 3) did not reflect any change in
the cycling compartment of the cell populations under
examination. This aspect of DHP action awaits further
investigation with the use of other incubation intervals
for cytochalasin B treatment, as well as the use of flow
cytometry to assess cell cycle progression.
It is tempting to assume that 1,4-DHP derivatives,
which belong to well known voltage-dependent Ca2+
channel blockers act through modulation of calcium ion
transport. There are some older positive reports, e.g.
diltiazem, a benzothiazepine calcium channel blocker,
alone or in combination with 1,4-DHP blockers,
protected against bone marrow damage (cytogenetic
damage, cell death) and mortality in whole body
irradiated mice [5−7]. Nevertheless, survival studies with
human cell lines (HeLa and MDA-MB-231) involving
blocking of the radiation-induced increase in cyto-
plasmic calcium concentration with another member
of 1,4-DHP family, nifedipine, did not reveal a
Table 2. Summary of DHP effects in LY cells, X-irradiated with approximately equitoxic doses (LY-R, 2 Gy; LY-S, 1 Gy)
Feature examined after DHP pre-treatment and X-irradiation LY-R LY-S
DNA breakage rejoining Slightly increased Unchanged
Micronuclei frequency Decreased by 27% Unchanged
Early lethal effect (48 h growth) Decreased by 43% Decreased by 14%
Viability (48 h after irradiation) Enhanced by 20% Enhanced by 60%
Fig. 3. Percentage of binucleated cells after 16 h incubation with cytochalasin B. (A) LY-R cells irradiated with 2 Gy X-rays
without or with DHP treatment at the concentrations indicated (DHP present 1 h before irradiation and during the whole
incubation interval). (B) LY-S cells irradiated with 1 Gy X-rays and treated as above. The differences between values obtained
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connection between the radiation effects on cellular
Ca2+ homeostasis and cell survival [21]. Other more
recent data indicate that calcium is required for ionising
radiation-induced cell cycle regulation and protein
kinase C activation, but the increase in cytoplasmic
calcium concentration is not a universal cellular response
to irradiation [10]. Finally, glutapyrone, unlike classical
1,4-DHPs, lacks calcium antagonistic or agonistic
properties, whereas it has an antimutagenic and anti-
neoplastic activity [9, 11, 12, 22].
The lack of dependence of the biological effects on
DHP concentration in the range of concentrations
studied (1 nM − 100 µM), suggests an all-or-none effect,
as in cellular signaling induction observed in radio-
adaptation [2, 18] or bystander effect (reviews in [1, 14,
17]. It should be added that radioadaptation has recently
been interpreted as a result of decrease in damage
fixation rather than repair stimulation [18]. Although
at present only an indirect support for such assumption
is available, it may be speculated that in the case of DHP
the antimutagenic effect is based on the same principle.
Furthermore, damage fixation is poly(ADP-ribose)
polymerase-dependent and its activity is modulated by
DHP [15]. The reported results must be treated as
preliminary, but they warrant further investigations
concerning the mechanisms of action of DHP in cells
with damaged DNA.
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